ProfileGDS4718 / 1566897_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 31% 43% 38% 34% 40% 43% 39% 40% 35% 27% 33% 48% 43% 34% 40% 30% 26% 40% 44% 56% 44% 37% 26% 31% 33% 31% 36% 58% 32% 36% 39% 39% 39% 29% 41% 39% 37% 42% 39% 27% 34% 38% 37% 38% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.5810131
GSM549102patient 115, normal, homogenized [OPG study]5.1442543
GSM549104patient 119, normal, homogenized [OPG study]4.8907338
GSM549108patient 138, normal, homogenized [OPG study]4.7414734
GSM549119patient 077, normal, homogenized [OPG study]5.0218740
GSM549133patient 032, cancer, homogenized [OPG study]5.0656243
GSM549139patient 042, cancer, homogenized [OPG study]4.9378139
GSM549099patient 107, normal, homogenized [OPG study]5.0208740
GSM549109patient 139, normal, homogenized [OPG study]4.7764935
GSM549110patient 046, normal, homogenized [OPG study]4.4243327
GSM549114patient 063, normal, homogenized [OPG study]4.6108633
GSM549122patient 082, normal, homogenized [OPG study]5.3886448
GSM549134patient 033, cancer, homogenized [OPG study]5.1507143
GSM549136patient 036, cancer, homogenized [OPG study]4.6650334
GSM549140patient 044, cancer, homogenized [OPG study]4.945240
GSM549111patient 047, normal, homogenized [OPG study]4.5034630
GSM549113patient 057, normal, homogenized [OPG study]4.3099426
GSM549132patient 031, cancer, homogenized [OPG study]4.9599240
GSM549137patient 038, cancer, homogenized [OPG study]5.1843344
GSM549142patient 047, cancer, homogenized [OPG study]5.990156
GSM549100patient 110, normal, homogenized [OPG study]5.2266744
GSM549107patient 135, normal, homogenized [OPG study]4.8202437
GSM549115patient 068, normal, homogenized [OPG study]4.3345426
GSM549116patient 072, normal, homogenized [OPG study]4.5804631
GSM549120patient 078, normal, homogenized [OPG study]4.6838233
GSM549131patient 030, cancer, homogenized [OPG study]4.5262131
GSM549118patient 074, normal, homogenized [OPG study]4.8041636
GSM549129patient 027, cancer, homogenized [OPG study]6.0277158
GSM549123patient 088, normal, homogenized [OPG study]4.6048832
GSM549124patient 006, cancer, homogenized [OPG study]4.8574236
GSM549126patient 015, cancer, homogenized [OPG study]4.9618739
GSM549128patient 025, cancer, homogenized [OPG study]4.9249739
GSM549103patient 117, normal, homogenized [OPG study]5.0182339
GSM549117patient 073, normal, homogenized [OPG study]4.480329
GSM549138patient 041, cancer, homogenized [OPG study]5.0045441
GSM549141patient 045, cancer, homogenized [OPG study]4.893539
GSM549130patient 028, cancer, homogenized [OPG study]4.8632637
GSM549101patient 111, normal, homogenized [OPG study]5.1377142
GSM549105patient 128, normal, homogenized [OPG study]4.9475339
GSM549106patient 134, normal, homogenized [OPG study]4.3849427
GSM549112patient 048, normal, homogenized [OPG study]4.695834
GSM549125patient 011, cancer, homogenized [OPG study]4.9284138
GSM549127patient 024, cancer, homogenized [OPG study]4.8577737
GSM549135patient 035, cancer, homogenized [OPG study]4.85638